ArticleMedical oncology (Northwood, London, England)2025

Anti-breast cancer activity of a novel genetically engineered fusion protein composed of HER2 affibody and proapoptotic peptide R8-KLA.

Jian Liu et al.PubMed ↗Publisher ↗

No numbers read from the abstract.